文献速递其他结缔组织病

从患者活检组织开发唾液腺类器官:干燥综合征的功能模型

Development of salivary gland organoids derived from patient biopsies: a functional model of Sjögren's disease.
PubMed 文献 · Ann Rheum Dis · 2025-05-20

研究从13例符合ACR/EULAR 2016标准的干燥综合征(SjD)患者和15例口干对照的小唾液腺活检(LSGB)中建立唾液腺类器官(SGO),可长期培养并表达腺泡、导管和肌上皮标志物,对炎症和胆碱能刺激有反应;SjD来源的分化SGO持续保持干扰素特征且肿胀能力降低,托法替尼可增强其肿胀能力。

要点

  • 从SjD患者和口干对照的LSGB均可建立SGO,长期培养活力相当(3.3 ± 1.7个月)。
  • SjD来源的分化SGO在长期培养中持续保持干扰素特征。
  • SjD来源的分化SGO肿胀能力较对照降低,托法替尼处理可增强其肿胀能力。

核心结论

  • 成功从SjD患者LSGB建立SGO,可长期培养并忠实再现疾病表型,该模型有望作为药物筛选的有价值工具。

研究设计与样本

  • 纳入符合ACR/EULAR 2016标准的SjD患者和口干对照,将LSGB解离后包埋于细胞外基质,在生长扩增培养基中长期培养,分化培养基中培养后转移至低吸附板形成分化SGO(DIF-SGO)。
  • 共纳入13例SjD和15例对照。

主要发现

  • 两组均形成SGO,长期培养活力相当,自我更新能力为3.3 ± 1.7个月。
  • 两组DIF-SGO相当地表达成熟腺泡(水通道蛋白5、淀粉酶)、导管(细胞角蛋白5和7)和肌上皮(α-平滑肌肌动蛋白)标志物。
  • DIF-SGO在聚肌胞苷酸(poly(I:C))和干扰素-α刺激下通过表达BAFF、CXCL10和IL7对炎症产生反应。
  • DIF-SGO对毛果芸香碱的胆碱能刺激表现出肿胀反应。
  • SjD来源的DIF-SGO在长期培养中持续保持干扰素特征,且肿胀能力较对照降低;托法替尼处理增强肿胀能力,提示对唾液分泌的潜在效应。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Salivary gland epithelial cells (SGECs) play a key role in Sjögren's disease (SjD) as an active contributor to the pathogenesis. Current models lack clear epithelial readouts. Our aim was to establish a more advanced model by developing salivary gland organoids (SGOs) from labial salivary gland biopsies (LSGBs) of SjD patients and sicca controls. METHODS: We included SjD patients fulfilling the American College of Rheumatology/European League Against Rheumatism 2016 criteria and sicca controls. LSGBs were dissociated, encapsulated in extracellular matrix, and submerged in growth expansion medium for long-term culture. SGOs were primarily cultured in differentiation medium and then transferred to a low attachment plate to form differentiated SGOs (DIF-SGOs). RESULTS: We included 13 SjD and 15 controls. In both groups, SGOs were formed, demonstrating long-term culture viability and comparable self-renewal capacity (3.3 ± 1.7 months). DIF-SGOs comparably exhibited mature acinar (aquaporin 5, amylase), ductal (cytokeratins 5 and 7) and myoepithelial (α-smooth muscle actin) markers in both groups. DIF-SGOs were responsive to inflammation by expressing BAFF, CXCL10 and IL7 upon stimulation with poly(I:C) and interferon-α. DIF-SGOs also demonstrated a swelling response to cholinergic stimulation by pilocarpine. We observed significant differences between SjD- and control-derived SGOs. Notably, SjD-derived DIF-SGOs consistently maintained a persistent interferon signature throughout long-term culture. In addition, the swelling capacity was reduced in SjD-derived DIF-SGOs compared to control. However, treatment with tofacitinib enhanced the swelling ability, suggesting a potential effect on saliva production. CONCLUSIONS: We successfully developed SGOs from LSGBs of SjD patients, allowing long-term culture and faithfully recapitulating the disease phenotype. This model holds promise as a valuable tool for drug screening.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Meudec L, Goudarzi N, Silva-Saffar SE, et al. Development of salivary gland organoids derived from patient biopsies: a functional model of Sjögren's disease. Ann Rheum Dis. 2025. PMID: 40393919. doi:10.1016/j.ard.2025.04.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。